We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study to Evaluate ITCA 650 Compared to Sitagliptin as add-on Therapy for the Treatment of Type 2 Diabetes

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01455870
Recruitment Status : Completed
First Posted : October 20, 2011
Last Update Posted : June 2, 2016
Sponsor:
Information provided by (Responsible Party):
Intarcia Therapeutics

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : July 2015
  Study Completion Date : July 2015
  Certification or Request for Extension to Delay Results Submission: May 13, 2016